Q301--NEW – STX Specialized Molecular Residual Disease Testing
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a sole-source, Indefinite Delivery Indefinite Quantity (IDIQ) Firm-Fixed-Price contract to Natera, Inc. for proprietary molecular genetic reference testing services. These services are essential for evaluating and monitoring transplant patients and cancer residual disease through the use of the Prospera molecular expression transplant assessment test and the Signatera Residual Disease Test (MRD). The government has identified Natera, Inc. as the sole provider because they possess the exclusive proprietary methodologies, assays, and bioinformatics platforms required to perform these specific tests, with no authorized distributors or alternative clinical sources available. The scope of work includes an estimated quantity of 35 Signatera tests (CPT Codes 81479, 81455) and 25 Prospera tests (CPT Code 81479). The contract will span five ordering periods, with performance taking place at VA facilities within VISN 17 in Texas. While this notice is not a formal request for quotes, interested parties may submit capability statements to Susan Flores by November 2, 2026, to demonstrate the existence of an equivalent proprietary test. The government retains discretion on whether to compete the requirement based on the responses received.
General Info
Place of Performance
TXSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
Special Notice
Page 3 of 3 Special Notice *= Required Field Special Notice
Page 1 of 3 1. NOTICE OF INTENT DESCRIPTION The Department of Veterans Affairs, Network Contracting Office (NCO) 17, located at 5441 Babcock Road, Suite 302, San Antonio, TX 78229, intends to award an Indefinite Delivery Indefinite Quantity (IDIQ) Firm Fixed Price contract with five ordering periods on a sole-source basis to: Natera, Inc. 13011 McCallen Pass Austin, TX 78752 This requirement is for proprietary molecular genetic reference testing services used in the evaluation and monitoring of transplant patients and cancer residual disease. 2. SUPPLIES/SERVICES Item 0001 Description: Signatera Only, CPT Codes 81479, 81455 Estimated Quantity: 35 Unit: Each Item 0002 Description: Prospera, CPT Code 81479 Estimated Quantity: 25 Unit: Each Natera is the sole provider of these proprietary medical laboratory tests, including: Prospera molecular expression transplant assessment test Signatera Residual Disease Test (MRD) (non liquid biopsy tumor typing) No other vendor possesses the proprietary methodologies, assays, or intellectual property required to perform these tests. 3. SOLE SOURCE JUSTIFICATION Testing required by the VA is proprietary to Natera, Inc. No authorized distributors, third party laboratories, or alternative clinical sources exist for the Prospera and Signatera MRD tests. These assays cannot be substituted or performed by any other laboratory. Only Natera maintains the necessary technology, reagents, and bioinformatics platforms. 4. THIS NOTICE IS NOT A REQUEST FOR QUOTES This Special Notice is issued solely for information and planning purposes. It does not constitute a solicitation or a request for competitive quotes. Interested parties may submit a capability statement demonstrating an ability to perform the required testing. Responses must clearly show that an equivalent proprietary test exists and can be provided. 5. RESPONSE INSTRUCTIONS Responses must be emailed to: Susan Flores Contract Specialist, NCO 17 Email: Susan.Flores2@va.gov
Deadline: November 2, 2026 at 10:00 AM CST
The Government will review all responses but retains discretion regarding whether to compete this requirement. The Government is not responsible for any costs incurred in responding to this notice.
6. PLACE OF PERFORMANCE VA Facilities within VISN 17 (Texas) Specific ordering locations will be identified in individual task/delivery orders.
7. PERIOD OF PERFORMANCE Five ordering periods (exact dates to be determined at award).
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
